Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.David D. Waters, Jacques Lespérance, B P Kimball et al.|Circulation|1994Cited by 505
Effects of Cigarette Smoking on the Angiographic Evolution of Coronary AtherosclerosisDavid D. Waters, Lyall Higginson, Jacques Lespe ́rance et al.|Circulation|1996Cited by 122
Effects of Cholesterol Lowering on the Progression of Coronary Atherosclerosis in WomenDavid D. Waters, Jacques Lespérance, Lyall Higginson et al.|Circulation|1995Cited by 67
Design features of a controlled clinical trial to assess the effect of an HMG CoA reductase inhibitor on the progression of coronary artery diseaseDavid D. Waters, Jacques Lespérance, Michel Lemay et al.|Controlled Clinical Trials|1993Cited by 17